AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease (NCT07512206) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease
United States200 participantsStarted 2026-04-01
Plain-language summary
The AERO CAD study is a prospective, multi-center, single-arm, post-market clinical investigation evaluating the procedural performance and clinical outcomes of the Shockwave C2 Aero Coronary Intravascular Lithotripsy (IVL) System in patients with calcified coronary artery disease undergoing percutaneous coronary intervention (PCI).
The study will enroll up to 200 subjects across up to 8 U.S. sites. The primary objective is to generate real-world evidence on device performance and clinical outcomes, including target lesion failure at 30 days and procedural success.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.